Femasys Inc., a biomedical company, focuses on women's healthcare market in the United States. The company develops permanent birth control solutions, such as FemBloc and FemChec; FemaSeed, an artificial insemination solution; FemCerv, a biopsy device for endocervical curettage; and FemEMB, a product candidate for endometrial sampling in support of uterine cancer detection testing. It also commercializes FemVue saline-air device in the United States, Europe, Canada, Japan, and internationally. The company offers its infertility products to obstetrics-gynecological physicians, related healthcare professionals, women's healthcare provider organizations, and reproductive endocrinologists. In addition, it provides non-surgical product technologies. Femasys Inc. was incorporated in 2004 and is based in Suwanee, Georgia.
The current price of FEMY is $0.52 USD — it has increased by +0.72% in the past 24 hours. Watch Femasys stock price performance more closely on the chart.
What is Femasys stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Femasys stocks are traded under the ticker FEMY.
Is Femasys stock price growing?▼
FEMY stock has fallen by -12.42% compared to the previous week, the month change is a -18.17% fall, over the last year Femasys has showed a -53.89% decrease.
What is Femasys market cap?▼
Today Femasys has the market capitalization of 30.39M
When is the next Femasys earnings date?▼
Femasys is going to release the next earnings report on March 26, 2026.
What were Femasys earnings last quarter?▼
FEMY earnings for the last quarter are -0.1 USD per share, whereas the estimation was -0.12 USD resulting in a +13.04% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Femasys revenue for the last year?▼
Femasys revenue for the last year amounts to 3.26M USD.
What is Femasys net income for the last year?▼
FEMY net income for the last year is -37.63M USD.
How many employees does Femasys have?▼
As of February 03, 2026, the company has 69 employees.